Biotech China 2014

Joseph P Hammang

TypeWhite Paper Summary

Good health is vital to all of us, and finding sustainable solutions to the health care challenges of our changing world cannot wait. That's why we at Pfizer are committed to being a global leader in health care and to helping change millions of lives for the better through providing access to safe, effective and affordable medicines and related health care services to the people who need them. We have a leading portfolio of medicines that prevent, treat and cure diseases across a broad range of therapeutic areas, and an industry-leading pipeline of promising new products in areas such as oncology, cardiovascular disease and diabetes.

To ensure that we deliver the value our patients and customers need and our shareholders deserve, we are focused on continually improving the way we do business; on operating with transparency in everything we do; and on listening to the views of all of the people involved in health care decisions. We know that we can best ensure that people everywhere have access to innovative medicines and quality health care through working in partnership with everyone from patients to health care providers, managed care organizations to world governments and non-governmental organizations.

Keywords
Authors
Name:Joseph P Hammang
Organizations
Organization:Pfizer

Previous Comments

4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.